1. Klastersky, J. Management of infection in granulocytopenic patients. J. Antimicrob. Chemother. 12 (1983) 102–104.
2. Meunier F. Infections in patients with acute leukemia and lymphoma. In:Mandell, G. L., Douglas, R. G., Bennett, J. E. (eds. Churchill Livingstone, New York 1989, pp. 2265–2275.
3. de Pauw, B. E., Feld, R., Deresinski, S., Donnelly, J. P., Lane-Allman, E.: Multicentre, randomized, comparative study of ceftazidime versus piperacillin + tobramycin as empirical therapy for febrile granulocytopenic patients. In: Proceedings of the 6th International Symposium on Infections in the Immunocompromised Host, 1990, 116A.
4. Report of a Consensus Panel of the Immunocompromised Host Society The design, analysis and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J. Infect. Dis. 161 (1990) 397–401.
5. Working Committee of the Infectious Diseases Society of America Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J. Infect. Dis. 161 (1990) 381–396.